References - Homocysteine in Protein Structure/Function and Human Disease - page 137

S-(carboxymethylthio) homocysteine, and S-(3-hydroxy-3-carboxy-n-propyl). Physiol Chem
Phys. 1972;4(3):286-94.
121. Hasegawa T, Ichiba M, Matsumoto SE, Kasanuki K, Hatano T, Fujishiro H, et al. Urinary
homocysteic acid levels correlate with mini-mental state examination scores in Alzheimer's
disease patients. J Alzheimers Dis. 2012;31(1):59-64.
122. Frauscher G, Karnaukhova E, Muehl A, Hoeger H, Lubec B. Oral administration of homo-
cysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms
in homocysteine induced endothelial damage? Life Sci. 1995;57(8):813-7.
123. Vijayanathan V, Gulinello M, Ali N, Cole PD. Persistent cognitive deficits, induced by
intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic
glutamate analogs and can be reversed by an NMDA antagonist. Behav Brain Res.
2011;225(2):491-7.
124. Hasegawa T, Mikoda N, Kitazawa M, LaFerla FM. Treatment of Alzheimer's disease with
anti-homocysteic acid antibody in 3xTg-AD male mice. PLoS One. 2010;5(1):e8593.
125. Waller SJ, Kilpatrick IC, Chan MW, Evans RH. The influence of assay conditions on
measurement of excitatory dibasic sulphinic and sulphonic alpha-amino acids in nervous
tissue. J Neurosci Methods. 1991;36(2-3):167-76.
126. Kopoldova J, Liebster J, Gross E. Radiation chemical reactions in aqueous solutions of
methionine and its peptides. Radiat Res. 1967;30(2):261-74.
127. Bern M, Saladino J, Sharp JS. Conversion of methionine into homocysteic acid in heavily
oxidized proteomics samples. Rapid commun mass spectrom. 2010;24(6):768-72.
128. Parker ET, Cleaves HJ, Dworkin JP, Glavin DP, Callahan M, Aubrey A, et al. Primordial
synthesis of amines and amino acids in a 1958 Miller H2S-rich spark discharge experiment.
Proc Natl Acad Sci USA. 2011;108(14):5526-31.
129. Van Trump JE, Miller SL. Prebiotic synthesis of methionine. Science. 1972;178
(4063):859-60.
130. Salojin KV, Cabrera RM, Sun W, Chang WC, Lin C, Duncan L, et al. A mouse model of
hereditary folate malabsorption: deletion of the PCFT gene leads to systemic folate defi-
ciency. Blood. 2011;117(18):4895-904.
131. Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and
homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit
Metab Dis. 2012;35(1):91-102.
132. Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria,
cblC type. II. Complications, pathophysiology, and outcomes. J Inherit Metab Dis. 2012;35
(1):103-14.
133. Undas A, Jakubowski H. Letter by Undas and Jakubowski regarding article, “Relationship
between homocysteine and mortality in chronic kidney disease”. Circulation. 2006;114(16):
e547. author reply e548.
134. Jakubowski H. Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease.
Clin Chem Lab Med. 2005;43(10):1011-4.
135. Undas A, Jankowski M, Twardowska M, Padjas A, Jakubowski H, Szczeklik A. Antibodies to
N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men.
Thromb Haemost. 2005;93(2):346-50.
136. Chambers JC, Obeid OA, Kooner JS. Physiological increments in plasma homocysteine
induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb
Vasc Biol. 1999;19(12):2922-7.
137. Chambers JC, Ueland PM, Wright M, Dore CJ, Refsum H, Kooner JS. Investigation of
relationship between reduced, oxidized, and protein-bound homocysteine and vascular endo-
thelial function in healthy human subjects. Circ Res. 2001;89(2):187-92.
138. Jakubowski H, Goldman E. Synthesis of homocysteine thiolactone by methionyl-tRNA
synthetase in cultured mammalian cells. FEBS Lett. 1993;317(3):237-40.
139. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation
in humans. J Nutr. 2000;130(2S Suppl):377S-81.